Innoviva (INVA) Cash from Operations (2010 - 2026)
Innoviva's Cash from Operations was $51.97 million in Q2 2026, up 17.9% from $44.07 million a year earlier and up 47.3% from the prior quarter.
Innoviva (INVA) Cash from Operations (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Innoviva's Cash from Operations was $191.49 million through Jun 30, 2026, down 4.5% year-over-year; for FY2025, it came in at $196.93 million, up 4.4% from FY2024.
- Cash from Operations shows a five-year compound annual growth rate of -8.9% (FY2020 to FY2025).
- In earlier years, Cash from Operations was $188.69 million in FY2024 (+33.8%), $141.06 million in FY2023 (-30.1%), $201.73 million in FY2022 (-44.6%) and $363.81 million in FY2021 (+16.2%).
- Quarterly Cash from Operations has moved between $25.68 million (Q1 2023) and $98.38 million (Q4 2021) over five years.
- Compared with a year earlier, Cash from Operations was higher in four of the last six quarters, with growth averaging 2.8%.
- The best year-over-year quarter for Cash from Operations over five years was Q1 2024 (growth of 44.2%); the worst was Q1 2023 (a decline of 73.8%).
- Per Business Quant data, INVA's Cash from Operations in the three quarters before Q2 2026 was $35.28 million (Q1 2026), $54.51 million (Q4 2025) and $49.73 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 8.62 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.44 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.37 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.88 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.58 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.00 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.57 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 835.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.13 Bn |
| 10 | Innoviva | 1.54 Bn | -750.13 Mn | 90.62 Mn | 51.97 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.97 Mn |
| Mar 31, 2026 | 35.28 Mn |
| Dec 31, 2025 | 54.51 Mn |
| Sep 30, 2025 | 49.73 Mn |
| Jun 30, 2025 | 44.07 Mn |
| Mar 31, 2025 | 48.62 Mn |
| Dec 31, 2024 | 59.24 Mn |
| Sep 30, 2024 | 48.69 Mn |
| Jun 30, 2024 | 43.72 Mn |
| Mar 31, 2024 | 37.05 Mn |
| Jun 30, 2023 | 38.18 Mn |
| Mar 31, 2023 | 25.68 Mn |
| Jun 30, 2022 | 79.04 Mn |
| Mar 31, 2022 | 98.10 Mn |
| Dec 31, 2021 | 98.38 Mn |
| Sep 30, 2021 | 96.71 Mn |
| Jun 30, 2021 | 84.61 Mn |
| Mar 31, 2021 | 84.11 Mn |
| Dec 31, 2020 | 85.28 Mn |
| Sep 30, 2020 | 74.56 Mn |
Innoviva Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=INVA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();